Literature DB >> 18415597

[Not Available].

U Thoden1.   

Abstract

Year:  1992        PMID: 18415597     DOI: 10.1007/BF02529699

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


× No keyword cloud information.
  23 in total

1.  Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883).

Authors:  S BLOM
Journal:  Lancet       Date:  1962-04-21       Impact factor: 79.321

2.  [Preliminary note on the action of imipramine in painful states].

Authors:  F PAOLI; G DARCOURT; P COSSA
Journal:  Rev Neurol (Paris)       Date:  1960-05       Impact factor: 2.607

3.  [Fifteen years of trial therapy of essential trigeminal neuralgia: the place of diphenylhydantoin and its derivatives].

Authors:  M BERGOUIGNAN
Journal:  Rev Neurol (Paris)       Date:  1958-05       Impact factor: 2.607

4.  Role of inhibitory mechanisms in trigeminal neuralgia.

Authors:  G H Fromm; A S Chattha; C F Terrence; J D Glass
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

5.  Carbamazepine. Pharmacology and clinical uses.

Authors:  M Sillanpää
Journal:  Acta Neurol Scand Suppl       Date:  1981

6.  Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up.

Authors:  G H Fromm; C F Terrence; A S Chattha
Journal:  Ann Neurol       Date:  1984-03       Impact factor: 10.422

Review 7.  Pain relief by antidepressants: possible modes of action.

Authors:  Charlotte Feinmann
Journal:  Pain       Date:  1985-09       Impact factor: 6.961

8.  Amitriptyline, but not lorazepam, relieves postherpetic neuralgia.

Authors:  M B Max; S C Schafer; M Culnane; B Smoller; R Dubner; R H Gracely
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

9.  Mexiletine for treatment of chronic painful diabetic neuropathy.

Authors:  A Dejgard; P Petersen; J Kastrup
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

10.  Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial.

Authors:  J A Rull; R Quibrera; H González-Millán; O Lozano Castañeda
Journal:  Diabetologia       Date:  1969-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.